Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Enhanced Assistance During Radiotherapy for Unmet Essential Needs [NA]
A completed clinical trial evaluated enhanced assistance during radiotherapy to address unmet essential needs across multiple cancer types.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Sexual Health Integration in Treatment of Gynecological Oncology
Completed clinical trial evaluating integration of sexual health support and counseling into gynecologic oncology care. The study includes p…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer [Phase 2]
This Phase 2 clinical trial evaluates regorafenib in combination with fulvestrant for recurrent low-grade serous ovarian cancer and is curre…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]
A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers [Phase 1]
This clinical trial update summarizes the Phase 1 study of STRO-002, an anti-Folate Receptor Alpha antibody-drug conjugate, in ovarian and e…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update on cabozantinib alone or with atezolizumab for locally advanced or metastatic solid tumors; the study lists mu…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update for SNS-101 (anti-VISTA) as monotherapy and in combination with cemiplimab in adults with advanced solid tumors, cur…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors [Phase 2]
A Phase 2 study of IBI363 in combination therapy for advanced solid tumors, including EGFR-mutant non-small cell lung cancer and platinum-re…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial of FT538 for recurrent ovarian, fallopian tube, and primary peritoneal cancer has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker [Phase 2]
Phase 2 clinical trial evaluating the combination of senaparib and bevacizumab as first-line maintenance therapy for newly diagnosed advance…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a T-cell therapy in combination with nivolumab, relatlimab, and ipilimumab in metastatic ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues [EARLY_Phase 1]
An early-phase 1 trial is investigating experimental PET imaging scans performed before cancer surgery to assess tracer uptake in normal and…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors [NA]
This clinical trial update discusses exploring plasma microRNA biomarkers to improve management of pelvic gynecologic tumors, focusing on ov…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Proactive Hemodynamic Management During Cytoreductive Surgery and HIPEC [NA]
This ClinicalTrials.gov entry describes a study on proactive hemodynamic management during cytoreductive surgery with HIPEC for ovarian canc…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients [NA]
A Mayo Clinic–sponsored clinical trial evaluating prehabilitation for patients with advanced ovarian, fallopian tube, or primary peritoneal …
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer [Phase 1]
Nuvectis Pharma's NXP800 is being studied in a Phase 1 trial for advanced solid tumors with expansion into ovarian cancer, and the study is …
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
The document reports a completed clinical trial focused on creating ex vivo ovarian tumor models to validate innovative therapies and identi…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers [Phase 1]
A Phase I trial of the radiopharmaceutical [177Lu]Lu-EVS459 in ovarian and lung cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Glove Compression for Chemotherapy-Induced Neuropathy [NA]
A completed clinical trial evaluated glove compression therapy for chemotherapy-induced peripheral neuropathy in patients with gynecologic c…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies [NA]
A ClinicalTrials.gov study evaluating re-irradiation for lateral pelvic recurrences in gynecologic cancers; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for TRK-950 in combination with anti-cancer regimens in patients with advanced solid tumors; the study is active but no…